Literature DB >> 17096103

[Anterior ischemic optic neuropathy and retinopathy during systemic interferon therapy].

M Moerchen1, A-K Rowton, K-H Emmerich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17096103     DOI： 10.1007/s00347-006-1434-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  9 in total

1.  [Severe, bilateral vision loss in malignant melanoma of the skin. Anterior ischemic optic neuropathy with irreversible vision and visual field loss in adjuvant interferon alfa-2b therapy].

Authors:  B Gabler; G Kroher; T Bogenrieder; D Spiegel; J Preuner; C P Lohmann
Journal:  Ophthalmologe       Date:  2001-07       Impact factor: 1.059

2.  [Interferon alpha-associated retinopathy in patients with chronic hepatitis C].

Authors:  S Schmidt; U Pleyer
Journal:  Klin Monbl Augenheilkd       Date:  2005-11       Impact factor: 0.700

3.  Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.

Authors:  S Sugano; T Suzuki; M Watanabe; K Ohe; K Ishii; T Okajima
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

Review 4.  [Interferon causes ischemic ocular diseases--case studies and review of the literature].

Authors:  B M Stoffelns
Journal:  Klin Monbl Augenheilkd       Date:  2006-05       Impact factor: 0.700

5.  Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.

Authors:  Louis d'Alteroche; Samuel Majzoub; Anne-Isabelle Lecuyer; Marie-Paule Delplace; Yannick Bacq
Journal:  J Hepatol       Date:  2005-08-18       Impact factor: 25.083

6.  Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.

Authors:  Joel A Schulman; Chanping Liang; Lakshmana M Kooragayala; John King
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

7.  [Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin].

Authors:  A Kirchhoff; U Kirchhoff; M Lafrenz; R Guthoff
Journal:  Klin Monbl Augenheilkd       Date:  2004-09       Impact factor: 0.700

8.  Interferon-associated retinopathy.

Authors:  D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal:  Arch Ophthalmol       Date:  1993-03

9.  Is screening for interferon retinopathy in hepatitis C justified?

Authors:  F M Cuthbertson; M Davies; M McKibbin
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.